Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia. [electronic resource]
Producer: 20030314Description: S47-8 p. digitalISSN:- 0939-5555
- Busulfan -- administration & dosage
- Graft vs Host Disease -- epidemiology
- Hematopoietic Stem Cell Transplantation -- mortality
- Humans
- Immunosuppressive Agents -- administration & dosage
- Leukemia, Lymphocytic, Chronic, B-Cell -- mortality
- Recurrence
- Remission Induction
- Survival Rate
- Transplantation Conditioning -- adverse effects
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.